ArticleBMC public health2025
Optimizing surveillance post-pandemic: an evaluation of COVID-19 and other respiratory virus surveillance systems in the Philippines, April 2023.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nipah virus and the lessons of COVID-19: are we prepared for the next pandemic threat?Infectious medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOn May 5, 2023, the World Health Organization removed the public health emergency of international concern (PHEIC) designation for the COVID-19 pandemic, noting reduced global risk of severe COVID-19 due to widespread infection and vaccine-induced immunity. Several months prior, the Philippine Department of Health (DOH) requested technical assistance from the U.S. Centers for Disease Control and Prevention (CDC) to evaluate its COVID-19 surveillance ecosystem and inform decision-making for sustainable respiratory virus monitoring. This manuscript describes the evaluation methodology, findings, and recommendations to inform these surveillance transitions.
methodsIn April 2023, an evaluation team from DOH, CDC, and Task Force for Global Health conducted a cross-sectional evaluation of six surveillance systems (COVID-19 case-based, traveler screening, and genomic surveillance; influenza-like illness surveillance, severe acute respiratory infection surveillance, and the Respiratory Syncytial Virus surveillance pilot) at 26 sites across three Philippine regions. Using tailored data collection tools, we analyzed systems’ structure, processes, attributes, and key performance indicators. Findings were categorized into three areas: surveillance system scope and design, system performance, and laboratory capacity.
resultsAlthough the DOH expanded and upgraded systems for COVID-19 surveillance, including universal case surveillance, contact tracing, and molecular testing and genomic sequencing, rapid development of multiple, isolated systems during the pandemic created inefficiencies and data discrepancies. Prioritizing COVID-19 surveillance strained staff capacity, impacting other surveillance efforts. Key findings included variable reporting completeness and timeliness and underutilization of sentinel sites. Challenges included fragmented data systems, heavy workloads, and resource limitations. Staff adaptability and dedication demonstrated their commitment to surveillance compliance. Progress in molecular testing and genomic sequencing was notable.
conclusionsPandemic-era surveillance of respiratory viruses requires adaptation to the interpandemic period. Recommendations focus on right-sizing COVID-19 surveillance while strengthening other surveillance systems, integrating respiratory virus surveillance systems, enhancing staff capacity, and improving stakeholder coordination. These findings offer valuable insights for transitioning to sustainable respiratory virus surveillance post-pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.